HomeClinical TopicsFDA approves new multiple sclerosis drug

FDA approves new multiple sclerosis drug

Author(s):

On March 27, the U.S. Food and Drug Administration (FDA) approved Tecfidera (dimethyl fumarate) capsules to treat adults with relapsing forms of multiple sclerosis. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

menopause and sleep problems

Menopause and Sleep Problems

Data shows that sleep disturbances increase in prevalence during the menopausal transition, with the most common complaint being nighttime awakenings. Take our quick three-question survey...